Literature DB >> 10484860

Cardiac pacemakers and implantable defibrillators in terminal care.

T C Braun1, N A Hagen, R E Hatfield, D G Wyse.   

Abstract

The use of cardiac pacemakers and arrhythmia control devices is increasingly common. The presence of a previously placed pacemaker or implantable cardioverter-defibrillator (ICD) in a terminally ill patient may result in medical and ethical issues for the patient, family, and healthcare provider. Two cases are presented to illustrate the complex issues that may arise in the terminally ill with a pacemaker or an ICD. Based on these cases and a review of published data, it is likely that the disabling of a previously placed pacemaker will neither hasten nor prolong the natural history of the underlying illness in most instances. There are uncommon but potentially severe adverse effects of disabling the pacemaker; therefore, pacemakers should generally be left intact in terminally ill patients. It is more difficult to generalize as to whether deactivation of an ICD is appropriate; in this case death may be hastened and the decision concerning an ICD will depend on the specific clinical scenario. Patient and family education regarding palliative care treatment goals and the function of pacemakers and other implanted arrhythmia control devices can help to alleviate anxiety surrounding the impact of this technology at the end of life.

Entities:  

Mesh:

Year:  1999        PMID: 10484860     DOI: 10.1016/s0885-3924(99)00038-x

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  3 in total

1.  Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients.

Authors:  Suraj Kapa; Paul S Mueller; David L Hayes; Samuel J Asirvatham
Journal:  Mayo Clin Proc       Date:  2010-09-15       Impact factor: 7.616

2.  The ethical and legal implications of deactivating an implantable cardioverter-defibrillator in a patient with terminal cancer.

Authors:  Ruth England; Tim England; John Coggon
Journal:  J Med Ethics       Date:  2007-09       Impact factor: 2.903

Review 3.  Within you/without you: biotechnology, ontology, and ethics.

Authors:  Daniel P Sulmasy
Journal:  J Gen Intern Med       Date:  2008-01       Impact factor: 5.128

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.